✦ LIBER ✦

Metabolomic analysis of urine and serum in Parkinson’s disease

✍ Scribed by Andrew W. Michell; David Mosedale; David J. Grainger; Roger A. Barker

Publisher: Springer
Year: 2008
Tongue: English
Weight: 393 KB
Volume: 4
Category: Article
ISSN: 1573-3882
DOI: 10.1007/s11306-008-0111-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Trace and major elements in whole blood,

Trace and major elements in whole blood, serum, cerebrospinal fluid and urine of patients with Parkinson’s disease

✍ G. Forte; B. Bocca; O. Senofonte; F. Petrucci; L. Brusa; P. Stanzione; S. Zannin 📂 Article 📅 2004 🏛 Springer 🌐 English ⚖ 98 KB

Metabolomic analysis and signatures in m

Metabolomic analysis and signatures in motor neuron disease

✍ Steve Rozen; Merit E. Cudkowicz; Mikhail Bogdanov; Wayne R. Matson; Bruce S. Kri 📂 Article 📅 2005 🏛 Springer 🌐 English ⚖ 579 KB

NMR-based metabolomic analysis of cerebr

NMR-based metabolomic analysis of cerebrospinal fluid and serum in neurological diseases – a diagnostic tool?

✍ Alexandra J. Sinclair; Mark R. Viant; Alexandra K. Ball; Michael A. Burdon; Eliz 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 372 KB

Postmortem analysis of pallidotomy in Pa

Postmortem analysis of pallidotomy in Parkinson’s disease

✍ Roongroj Bhidayasiri; Hajime Miyata; Jeff M. Bronstein; Jeffrey Schweitzer; Pete 📂 Article 📅 2005 🏛 Springer 🌐 English ⚖ 270 KB

Serum prolactin levels in Parkinson's di

Serum prolactin levels in Parkinson's disease and multiple system atrophy

✍ Andrea Sylvia Winkler; Sabine Landau; K Ray Chaudhuri 📂 Article 📅 2002 🏛 Springer 🌐 English ⚖ 223 KB

Serum urate and probability of dopaminer

Serum urate and probability of dopaminergic deficit in early “Parkinson's disease”

✍ Michael A. Schwarzschild; Kenneth Marek; Shirley Eberly; David Oakes; Ira Shouls 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 100 KB

The objective of this study was to investigate whether higher levels of urate, an antioxidant linked to a lower likelihood of developing Parkinson's disease, is also a predictor of having a dopamine transporter brain scan without evidence of dopaminergic deficit. In a cross-sectional study of 797 mi